2013

2013 (8 Publikationen)

  • Leitritz MA, Gelisken F, Ziemssen F, Szurman P, Bartz-Schmidt KU, Jaissle GB. Grid laser photocoagulation for macular oedema due to branch retinal vein occlusion in the age of bevacizumab? Results of a prospective study with crossover design. Br J Ophthalmol 2013; 97: 215-219 [2.917]
  • Schnichels S, Hagemann U, Januschowski K, Hofmann J, Bartz-Schmidt KU, Szurman P, Spitzer MS, Aisenbrey S. Comparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on different ocular cells. Br J Ophthalmol 2013; 97: 917-923 [2.917]
  • Schultheiss M, Januschowski K, Ruschenburg H, Schramm C, Schnichels S, Szurman P, Bartz-Schmidt KU, Spitzer MS. Dulbecco's Modified Eagle Medium is neuroprotective when compared to standard vitrectomy irrigation solution. Graefes Arch Clin Exp Ophthalmol 2013; 251: 1613-1619 [2.102]
  • Yoeruek E, Bayyoud T, Hofmann J, Szurman P, Bartz-Schmidt KU. Reply. Cornea 2013; 32: 139 [IF 1.853]
  • Sobolewska B, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P, Yoeruek E. Antiproliferative and cytotoxic properties of moxifloxacin on rat retinal ganglion cells. Curr Eye Res 2013; 38: 662-669 [IF 1.519]
  • Veckeneer M, Mohr A, Alharthi E, Azad R, Bashshur ZF, Bertelli E, Bejjani RA, Bouassida B, Bourla D, Crespo IC, Fahed C, Fayyad F, Mura M, Nawrocki J, Rivett K, Scharioth GB, Shkvorchenko DO, Szurman P, Van Wijck H, Wong IY, Wong DS, Frank J, Oellerich S, Bruinsma M, Melles GR. Novel 'heavy' dyes for retinal membrane staining during macular surgery: multicenter clinical assessment. Acta Ophthalmol 2014; 92: 339-344 [2.441]
  • Januschowski K, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Meyer CH, Szurman GB. Injection scheme for intravitreal bevacizumab therapy for macular edema due to central retinal vein occlusion: results of a multicenter study. Graefes Arch Clin Exp Ophthalmol 2013; 2015; 93:e400-402 Epub ahead of print [2.102]
  • Kitiratschky V, Deuter C, Beck R, Schulte B, Müller H, Blumenstock G, Bartz-Schmidt KU, Szurman P. Relationship between suspected reasons of intraocular inflammation and the results of diagnostic vitrectomy: an observational study. Br J Ophthalmol 2015; 23: 59-66 Epub ahead of print [IF 2.917]

Kontakt

Callcenter:
06897 / 574-1121

E-Mail-Formular

Notfallambulanz (Pforte, außerhalb der Callcenter-Sprechzeiten):
06897 / 574-0

Privatambulanz (Chefarzt-Sekretariat):
06897 / 574-1119

Adresse:
Augenklinik Sulzbach, An der Klinik 10
66280 Sulzbach

Anfahrt

Kontakt

Logo KHERI augenklinik saar

KTQ Zertifikat

Wussten Sie schon?

Unser hohes Maß an Qualität wurde uns als erster Klinik im Saarland offiziell zertifiziert. Das KTQ-Siegel steht für Patientenorientierung, geprüfte Qualität und Sicherheit.